Concord Medical Services Holdings Limited (CCM) Stock

Concord Medical Services Holdings Limited, based in Beijing, the People's Republic of China, operates an extensive network of radiotherapy and diagnostic imaging centers through its subsidiaries. The company's operations are divided into two primary segments: Network and Hospital.

Within its Network segment, Concord Medical provides a variety of advanced medical services including linear accelerator external beam radiotherapy, gamma knife radiosurgery, head and body gamma knife systems, and diagnostic imaging services such as computed tomography (CT) scanners. These services are complemented by clinical support offerings that include treatment protocol development, joint diagnosis facilitation among network doctors, clinical research support, and assistance with medical personnel recruitment and compensation.

Additionally, Concord Medical offers equipment leasing and management services for radiotherapy and diagnostic equipment, premium cancer and proton treatment services, teleconsultation, medical information technology solutions, and sales of medical equipment. The company also operates specialty cancer hospitals that provide comprehensive oncology services encompassing radiotherapy, diagnostic imaging, chemotherapy, and surgical interventions. As of December 31, 2021, Concord Medical operated a network of 16 cooperative centers across 13 hospitals, positioning itself as a leader in advanced medical care and cancer treatment solutions in China.